$CSTM

Deslarzes Jean-Christophe purchased $41K of CSTM

Deslarzes Jean-Christophe purchased 1,490 shares of CONSTELLIUM SE (CSTM) at $27.24 on 2026-08-03.

Original reporting
SEC EDGAR · Deslarzes Jean-Christophe
Published Aug 3, 2026, 11:25 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 3, 2026, 11:28 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CSTM
Neutral
medium confidence
Mentioned
$CSTM
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CSTMNeutralLow
01

Why it matters

A director-level open-market purchase was reported with exact share count, price, and post-transaction holdings, but no other company-specific catalyst is included.

02

Market read

Traders may note the fresh insider buy, but the disclosure lacks additional fundamentals that would justify a high-conviction trade.

03

What to watch

The filing notes no pre-arranged 10b5-1 plan, but the article does not provide context such as prior trading patterns, compensation timing, or whether the buy was funded by liquidity events.

Relevance 4/10Novelty 5/10Timing: filed on 2026-08-03, transaction dated 2026-08-03

Background

This is an SEC Form 4 insider transaction disclosure for Constel­lium SE (CSTM).

Company-level read

Ticker impact

$CSTMNeutralMedium confidence
Context

Constellium SE insider Deslarzes Jean-Christophe bought 1,490 shares on 2026-08-03 at $27.2400 via an open-market purchase.

Expected impact

Low likelihood of a sustained price move; any near-term reaction would be sentiment-driven and typically fades.

Evidence & confidence

Form 4 provides a fresh, primary-source transaction date and price, but the article contains no accompanying guidance, operational update, or material corporate event.

Market effects

No sector-level implications are provided beyond a single insider transaction.

None indicated.

None indicated.

Counterpoint

Insider buys can be opportunistic and do not necessarily signal undervaluation, especially when transaction size is small relative to company market cap.

Key entities

  • Constellium SE

    Subject of the Form 4 insider transaction disclosure (CSTM).

  • Deslarzes Jean-Christophe

    Director who reported an open-market purchase of 1,490 shares on 2026-08-03.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CSTMHighAI 8/10

Constellium shares jump 4% on strong earnings beat and raised guidance

Constellium SE (NYSE: CSTM) reported Q3 earnings of $0.84 per share, beating estimates by $0.21, with revenue up 22% YoY to $2.6B. The company raised its full-year 2026 adjusted EBITDA guidance to $1.03B-$1.06B. Shares rose 4.4% in pre-market trading. CEO Ingrid Joerg highlighted strong performance across all segments, including record EBITDA in Packaging & Automotive Rolled Products and Aerospace & Transportation.

$CSTMHigh

Constellium Reports Strong Third Quarter 2026 Results; Raises Full Year 2026 Guidance Paris - Constellium SE today reported results for the…

CONSTELLIUM SE (CSTM) filed an SEC Form 8-K — Results of Operations and Financial Condition. October 28, 2026 Constellium Reports Strong Third Quarter 2026 Results; Raises Full Year 2026 Guidance Paris - Constellium SE (NYSE: CSTM) ("Constellium" or the "Company") today reported results for the third quarter and the nine months ended September 30, 2026. Third quarter 202